{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:53:11Z","timestamp":1777992791229,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.berh.2019.101478","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T18:10:44Z","timestamp":1580148644000},"page":"101478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Established rheumatoid arthritis. The pathogenic aspects"],"prefix":"10.1016","volume":"33","author":[{"given":"Serena","family":"Bugatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Bozzalla Cassione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovico","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2019.101478_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","article-title":"Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis","volume":"13","author":"Catrina","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrrheum.2017.185","article-title":"Preventing progression from arthralgia to arthritis: targeting the right patients","volume":"14","author":"van Steenbergen","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives","volume":"5","author":"Burgers","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2019.101478_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","article-title":"Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts","volume":"74","author":"van Nies","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2019.101478_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrrheum.2017.161","article-title":"Synovial tissue research: a state-of-the-art review","volume":"13","author":"Orr","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780400206","article-title":"Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity","volume":"40","author":"Tak","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.59.12.945","article-title":"Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity","volume":"59","author":"Baeten","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000951","article-title":"Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score","volume":"5","author":"Just","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2019.101478_bib10","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar2744","article-title":"Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia","volume":"11","author":"Lequerr\u00e9","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib11","doi-asserted-by":"crossref","first-page":"R825","DOI":"10.1186\/ar1751","article-title":"Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens","volume":"7","author":"Tsubaki","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11926-011-0201-y","article-title":"Synovial tissue heterogeneity and peripheral blood biomarkers","volume":"13","author":"Bugatti","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2019.101478_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.berh.2019.101478_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib15","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib17","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2019.101478_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fmed.2019.00046","article-title":"Synovial tissue: turning the page to precision medicine in arthritis","volume":"6","author":"Triaille","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.berh.2019.101478_bib19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.23505","article-title":"Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype","volume":"58","author":"Thurlings","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2010.139287","article-title":"Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time?","volume":"70","author":"van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/rheumatology\/keu163","article-title":"High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease","volume":"53","author":"Bugatti","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.101478_bib22","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar3742","article-title":"Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs","volume":"14","author":"Bugatti","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib23","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar4552","article-title":"Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels","volume":"16","author":"Jones","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41467-017-02659-x","article-title":"Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation","volume":"9","author":"Stephenson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2019.101478_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib26","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20170910","article-title":"The transcriptional program, functional heterogeneity, and clinical targeting of mast cells","volume":"214","author":"Cildir","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.berh.2019.101478_bib27","doi-asserted-by":"crossref","first-page":"E2040","DOI":"10.3390\/ijms20082040","article-title":"Mast cells in early rheumatoid arthritis","volume":"20","author":"Rivellese","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.berh.2019.101478_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/ard.54.7.549","article-title":"Distribution, activation and tryptase\/chymase phenotype of mast cells in the rheumatoid lesion","volume":"54","author":"Tetlow","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/annrheumdis-2018-213418","article-title":"Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production","volume":"77","author":"Rivellese","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13075-016-0970-9","article-title":"Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission","volume":"18","author":"Ram\u00edrez","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib31","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.berh.2019.101478_bib32","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3899\/jrheum.150644","article-title":"Altered natural killer cell subsets in seropositive arthralgia and early rheumatoid arthritis are associated with autoantibody status","volume":"43","author":"Chalan","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib33","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A\u00a0subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib34","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.173.10.6418","article-title":"CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation","volume":"173","author":"Dalbeth","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib35","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41598-018-37448-z","article-title":"High percentages and activity of synovial fluid NK cells present in patients with advanced stage active Rheumatoid Arthritis","volume":"9","author":"Yamin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2019.101478_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/art.23264","article-title":"Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells","volume":"58","author":"Chan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib37","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/art.39244","article-title":"Dysregulated osteoclastogenesis is related to natural killer T cell dysfunction in rheumatoid arthritis","volume":"67","author":"Jin","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.40068","article-title":"Review: innate lymphoid cells: sparking inflammatory rheumatic disease?","volume":"69","author":"Wenink","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/art.39811","article-title":"Brief report: altered innate lymphoid cell subsets in human lymph node biopsy specimens obtained during the at-risk and earliest phases of rheumatoid arthritis","volume":"69","author":"Rodr\u00edguez-Carrio","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib40","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ajpath.2015.03.012","article-title":"Tertiary lymphoid structures in rheumatoid arthritis: NF-\u03baB-inducing kinase-positive endothelial cells as central players","volume":"185","author":"Noort","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.berh.2019.101478_bib41","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2019.101478_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/art.1780351209","article-title":"Rheumatoid synovium is enriched in Cd45rbdim mature memory T-cells that are potent helpers for B-cell differentiation","volume":"35","author":"Thomas","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/annrheumdis-2011-200612","article-title":"Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease","volume":"71","author":"Klarenbeek","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq0305","article-title":"Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis","volume":"10","author":"Fonseka","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.berh.2019.101478_bib45","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/art.23966","article-title":"Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint","volume":"58","author":"Manzo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib46","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.38173","article-title":"A\u00a0distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium","volume":"65","author":"Kobayashi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.berh.2019.101478_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib49","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20062259","article-title":"T\u00a0cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis","volume":"204","author":"Hirota","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2019.101478_bib51","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib52","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/ard.2007.080341","article-title":"Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis","volume":"67","author":"Yamada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib53","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-017-1305-1","article-title":"Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis","volume":"19","author":"Penatti","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.40070","article-title":"Secukinumab in active rheumatoid arthritis: a phase iii randomized, double-blind, active comparator- and placebo-controlled study","volume":"69","author":"Blanco","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib59","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.berh.2019.101478_bib60","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/art.40323","article-title":"A\u00a0randomized phase IIb study of mavrilimumab and golimumab in rheumatoid arthritis","volume":"70","author":"Weinblatt","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2019.101478_bib63","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid","volume":"50","author":"van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib64","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/eji.201344140","article-title":"Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion","volume":"44","author":"Herrath","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2019.101478_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.berh.2019.101478_bib67","doi-asserted-by":"crossref","first-page":"26021","DOI":"10.1038\/srep26021","article-title":"Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients","volume":"6","author":"Chalan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2019.101478_bib68","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib69","doi-asserted-by":"crossref","first-page":"11596","DOI":"10.1038\/ncomms11596","article-title":"Th2 and eosinophil responses supress inflammatory arthritis","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2019.101478_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrrheum.2016.74","article-title":"CD8(+) T cells in human autoimmune arthritis: the unusual suspects","volume":"12","author":"Petrelli","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib71","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2019.101478_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2019.02.001","article-title":"Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis","volume":"99","author":"Cammarata","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2019.101478_bib73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.berh.2019.101478_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/ard.2009.124966","article-title":"Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15?","volume":"70","author":"Kuca-Warnawin","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128269","article-title":"Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response","volume":"10","author":"Adlowitz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2019.101478_bib76","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/annrheumdis-2012-202861","article-title":"Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity","volume":"73","author":"Doorenspleet","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","article-title":"Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients","volume":"62","author":"Snir","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib78","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","article-title":"Nonclassical Ly6C(\u2212) monocytes drive the development of inflammatory arthritis in mice","volume":"9","author":"Misharin","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2019.101478_bib79","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib80","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/rheumatology\/36.9.935","article-title":"Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane","volume":"36","author":"Cauli","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib81","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.1251414","article-title":"The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal","volume":"344","author":"Rosas","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.berh.2019.101478_bib82","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar3796","article-title":"Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis","volume":"14","author":"Ambarus","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101478_bib83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.62.4.303","article-title":"Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints","volume":"62","author":"Smith","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib84","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fimmu.2019.01146","article-title":"Ontogeny of synovial macrophages and the roles of synovial macrophages from different origins in arthritis","volume":"10","author":"Tu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2019.101478_bib85","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/annrheumdis-2016-210424","article-title":"Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?","volume":"76","author":"Alivernini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib86","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.berh.2019.101478_bib87","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.berh.2019.101478_bib88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2019.101478_bib89","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1073\/pnas.1506254112","article-title":"IRF5 controls both acute and chronic inflammation","volume":"112","author":"Weiss","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"491","key":"10.1016\/j.berh.2019.101478_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8587","article-title":"HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness","volume":"11","author":"Kuo","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.berh.2019.101478_bib91","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","article-title":"Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis","volume":"64","author":"Haringman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib92","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41584-018-0112-7","article-title":"Pathogenic stromal cells as therapeutic targets in joint inflammation","volume":"14","author":"Dakin","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.101478_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/gm444","article-title":"An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype","volume":"5","author":"Whitaker","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.berh.2019.101478_bib94","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1038\/ncomms14852","article-title":"Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions","volume":"8","author":"Frank-Bertoncelj","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2019.101478_bib95","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1038\/s41598-018-24240-2","article-title":"Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis","volume":"8","author":"Karouzakis","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2019.101478_bib96","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/art.39123","article-title":"DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis","volume":"67","author":"Ai","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101478_bib97","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/annrheumdis-2017-211286","article-title":"Identification of a transitional fibroblast function in very early rheumatoid arthritis","volume":"76","author":"Filer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.101478_bib98","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2019.101478_bib99","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:19:02Z","timestamp":1761499142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219301743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1521694219301743"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.101478","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established rheumatoid arthritis. The pathogenic aspects","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.101478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101478"}}